Among these drug-attacked nodes, LTF, PPARG, and APOA2 have been proven to be targets for hypertension treatment (Ruiz-Giménez et al., 2012; Ballester et al., 2016; Toffoli et al., 2017). This evidence concerns the gene APOA2 and hypertensive disorder.